Alidac Pharmaceuticals' Ahmedabad facility completes USFDA inspection

With Zero observations

Cadila Healthcare announced that the USFDA inspected the manufacturing facility of Alidac Pharmaceuticals, the company's wholly-owned subsidiary, located at SEZ, Ahmedabad from 27 January to 4 February 2020. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectable for the regulated markets.

Powered by Capital Market - Live News